Press Releases

Date Title and Summary Additional Formats
Toggle Summary Financial Results For Third Quarter 2013
Strong Q3 2013 revenue growth of 43%
View HTML
Toggle Summary Fluidigm Q3 2013 Financial Results
Fluidigm to Announce Q3 2013 Financial Results and Host Conference Call for Investors
View HTML
Toggle Summary Fluidigm At The Credit Suisse 2013 Healthcare Conference
Fluidigm to Present at the Credit Suisse 2013 Healthcare Conference
View HTML
Toggle Summary Fluidigm And Nanostring Agree To Litigation Settlement
Fluidigm and Nanostring Agree to Litigation Settlement NanoString to Refrain From Using Single-Cell Comparison Study Marketing Materials
View HTML
Toggle Summary C1 Single-Cell Auto Prep System Wins Prestigious Award
Fluidigm C1 Single-Cell Auto Prep System Wins Prestigious IBO Design Award Recognized for Excellence in Analytical Instrument Industrial Design
View HTML
Toggle Summary Fluidigm Reports Strong Q2 2013 Revenue Growth Of 35%
Fluidigm Reports Strong Q2 2013 Revenue Growth Of 35% Record Instrument Revenue Driven by Rapidly Growing Single-Cell Genomics Market
View HTML
Toggle Summary Study Of Mirna Master Regulators Down To The Single Cell Lev
Fluidigm Enables the Study of miRNA Master Regulators Down to the Single Cell Level C1TM System Provides Simplest, Most Sensitive Method to Investigate Gene Regulation
View HTML
Toggle Summary 6 Samples Across 92 Proteins In One Microfluidic Run
Fluidigm and Olink Bioscience Bring a New Level of Protein Biomarker Discovery to the Market
View HTML
Toggle Summary Fluidigm To Announce Q2 2013 Financial Results
Fluidigm to Announce Q2 2013 Financial Results and Host Conference Call for Investors
View HTML
Toggle Summary Saskatchewan Disease Control Lab Selects Fluidigm Biomarkâ„¢HD
Rapid Detection of Pathogens Will Help Control Threats such as Flu Pandemic and SARS Rapid Detection of Pathogens by the Fluidigm System Will Help Control Serious Threats to Public Health such as Flu Pandemics and SARS.
View HTML